{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:55:42Z","timestamp":1790690142275,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00535-020-01679-7","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:03:02Z","timestamp":1583164982000},"page":"701-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Takuya","family":"Seike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikari","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriho","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"1679_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1679_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from American Association for the Study of Liver Disease. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"1679_CR3","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006;43:S54\u2013S64.","journal-title":"Hepatology"},{"key":"1679_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","volume":"58","author":"JR Henning","year":"2013","unstructured":"Henning JR, Graffero CS, Rehman A, et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology. 2013;58:589\u2013602.","journal-title":"Hepatology"},{"key":"1679_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u20137.","journal-title":"Nature"},{"key":"1679_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","volume":"59","author":"S Sutti","year":"2014","unstructured":"Sutti S, Jindal A, Locatelli I, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59:886\u201397.","journal-title":"Hepatology"},{"key":"1679_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/liv.12685","volume":"35","author":"K Yamada","year":"2015","unstructured":"Yamada K, Mizukoshi E, Sunagozaka H, et al. Characteristic of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis. Liver Int. 2015;35:582\u201390.","journal-title":"Liver Int"},{"key":"1679_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implication. Gastroenterology. 2012;142:711\u201325.","journal-title":"Gastroenterology"},{"key":"1679_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00535-018-1451-5","volume":"53","author":"Y Akazawa","year":"2018","unstructured":"Akazawa Y, Nakao K. To die or not to die: death signaling in nonalcoholic fatty liver disease. J Gastroenterol. 2018;53:893\u2013906.","journal-title":"J Gastroenterol"},{"key":"1679_CR10","doi-asserted-by":"publisher","first-page":"39336","DOI":"10.1074\/jbc.M111.280420","volume":"286","author":"SC Cazanave","year":"2011","unstructured":"Cazanave SC, Mott JL, Bronk SF, et al. Death receptor 5 signaling promotes hepatocytes lipoapoptosis. J Biol Chem. 2011;286:39336\u201348.","journal-title":"J Biol Chem"},{"key":"1679_CR11","first-page":"483","volume":"13","author":"AJ de Jong","year":"2014","unstructured":"de Jong AJ, Kloppenburg M, Toes RE, et al. Fatty acids, lipid mediators, and T-cell function. Front Immunol. 2014;13:483.","journal-title":"Front Immunol"},{"key":"1679_CR12","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2017.01949","volume":"8","author":"D Howie","year":"2018","unstructured":"Howie D, Ten Bokum A, Necula AS, et al. The role of lipid metabolism in T lymphocyte differentiation and survival. Front Immunol. 2018;8:1949.","journal-title":"Front Immunol"},{"key":"1679_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","volume":"36","author":"M Lochner","year":"2015","unstructured":"Lochner M, Berod L, Sparwasser T. Fatty acid metabolism in the regulation of T cell function. Trends Immunol. 2015;36:81\u201391.","journal-title":"Trends Immunol"},{"key":"1679_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1679_CR15","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/hep.21203","volume":"43","author":"E Mizukoshi","year":"2006","unstructured":"Mizukoshi E, Nakamoto Y, Marukawa Y, et al. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology. 2006;43:1284\u201394.","journal-title":"Hepatology"},{"key":"1679_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nri.2015.1","volume":"16","author":"MD Rosenblum","year":"2016","unstructured":"Rosenblum MD, Way SS, Abbas AK. Regulatory T cell memory. Nat Rev Immunol. 2016;16:90\u2013101.","journal-title":"Nat Rev Immunol"},{"key":"1679_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280\u201395.","journal-title":"J Hepatol"},{"key":"1679_CR18","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/jgh.14654","volume":"34","author":"K Yamada","year":"2019","unstructured":"Yamada K, Mizukoshi E, Seike T, et al. Serum C16:1n7\/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2019;34:1829\u201335.","journal-title":"J Gastroenterol Hepatol"},{"key":"1679_CR19","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.lfs.2005.07.038","volume":"78","author":"MF Cury-Boaventura","year":"2006","unstructured":"Cury-Boaventura MF, Pompeia C, Curi R. Comparative toxicity of oleic acid and linoleic acid on human lymphocytes. Life Sci. 2006;78:1448\u2013566.","journal-title":"Life Sci"},{"key":"1679_CR20","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1158\/1078-0432.CCR-16-3107","volume":"23","author":"M Altan","year":"2017","unstructured":"Altan M, Pelekanou V, Schalper KA, et al. B7\u2013H3 expression in NSCLC and its association with B7\u2013H4, PD-L1 and tumor-infiltrating lymphocyte. Clin Cancer Res. 2017;23:5202\u20139.","journal-title":"Clin Cancer Res"},{"key":"1679_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau M, Schilling AK, Meertens J, et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ration in peripheral blood and in the liver. J Immunol. 2016;196:97\u2013105.","journal-title":"J Immunol"},{"key":"1679_CR22","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","volume":"31","author":"ME Inzaugarat","year":"2011","unstructured":"Inzaugarat ME, Ferreyra Solari NE, Billordo LA, et al. Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol. 2011;31:1120\u201330.","journal-title":"J Clin Immunol"},{"key":"1679_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1165\/rcmb.2017-0326OC","volume":"58","author":"K Ni","year":"2018","unstructured":"Ni K, Liu M, Zheng J, et al. PD1\/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice. Am J Respir Cell Mol Biol. 2018;58:684\u201395.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1679_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2015.09.005","volume":"64","author":"X Zhang","year":"2016","unstructured":"Zhang X, Han J, Man K, et al. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. J Hepatol. 2016;64:160\u201370.","journal-title":"J Hepatol"},{"key":"1679_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/j.1460-2075.1990.tb08211.x","volume":"9","author":"S Mallett","year":"1990","unstructured":"Mallett S, Fossum S, Barclay AN. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes\u2014a molecule related to nerve growth factor receptor. EMBO J. 1990;9:1063\u20138.","journal-title":"EMBO J"},{"key":"1679_CR26","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4049\/jimmunol.166.4.2505","volume":"166","author":"H Sabzevari","year":"2005","unstructured":"Sabzevari H, Kantor J, Jaigirdar A, et al. Acquisition of CD80 (B7\u20131) by T cells. J Immunol. 2005;166:2505\u201313.","journal-title":"J Immunol"},{"key":"1679_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","volume":"26","author":"TR Malek","year":"2008","unstructured":"Malek TR. The biology of interleukin-2. Annu Rev Immunol. 2008;26:453\u201379.","journal-title":"Annu Rev Immunol"},{"key":"1679_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri1435","volume":"4","author":"TR Malek","year":"2004","unstructured":"Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL2. Nat Rev Immunol. 2004;4:665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1679_CR29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","volume":"31","author":"ME Inzaugarat","year":"2011","unstructured":"Inzaugarat ME, Ferreyra Solari NE, Billordo LA, Abecasis R, Gadano AC, Chernavsky AC. Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol. 2011;31:1120\u201330.","journal-title":"J Clin Immunol"},{"key":"1679_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/hep.21541","volume":"45","author":"A Penna","year":"2007","unstructured":"Penna A, Pilli M, Zerbini A, et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology. 2007;45:588\u2013601.","journal-title":"Hepatology"},{"key":"1679_CR31","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557\u2013655.","journal-title":"Hepatology"},{"key":"1679_CR32","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00535-018-1468-9","volume":"53","author":"K Kakisaka","year":"2018","unstructured":"Kakisaka K, Suzuki Y, Fujiwara Y, et al. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol. 2018;53:1285\u201391.","journal-title":"J Gastroenterol"},{"key":"1679_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00535-019-01565-x","volume":"54","author":"A Kado","year":"2019","unstructured":"Kado A, Tsutsumi T, Enooku K, et al. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells. J Gastroenterol. 2019;54:730\u201341.","journal-title":"J Gastroenterol"},{"key":"1679_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1679_CR35","doi-asserted-by":"publisher","first-page":"17892","DOI":"10.1073\/pnas.0906070106","volume":"106","author":"M Niedermeier","year":"2009","unstructured":"Niedermeier M, Reich B, Rodriguez Gomez M, et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrosis. Proc Natl Acad Sci USA. 2009;106:17892\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1679_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/hep.23094","volume":"50","author":"K Fujita","year":"2009","unstructured":"Fujita K, Nozaki Y, Wada K, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology. 2009;50:772\u201380.","journal-title":"Hepatology"},{"key":"1679_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1054\/clnu.2001.0529","volume":"21","author":"IT de Almeida","year":"2002","unstructured":"de Almeida IT, Cortez-Pinto H, Fidalgo G, et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr. 2002;21:219\u201323.","journal-title":"Clin Nutr"},{"key":"1679_CR38","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","volume":"26","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis N, Bardhan K, Chatterjee P, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun. 2015;26:6692.","journal-title":"Nat Commun"},{"key":"1679_CR39","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.26937","volume":"59","author":"VL Gadd","year":"2014","unstructured":"Gadd VL, Skoien R, Powell EE, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59:1393\u2013405.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01679-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-020-01679-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01679-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T01:31:57Z","timestamp":1614648717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-020-01679-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1679"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01679-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}